2017年

Sawada L, Nagano Y, Hasegawa A, Kanai H, Nogami K, Ito S, Sato T, Yamano Y, Tanaka Y, Masuda T, Kannagi M.
IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.
PLOS Pathogen, 13(9):e1006597, 2017.

Kuramitsu M, Sekizuka T, Yamochi T, Firouzi S, Sato T, Umeki K, Sasaki D, Hasegawa H, Kubota R, Sobata R, Matsumoto C, Kaneko N, Momose H, Araki K, Saito M, Nosaka K, Utsunomiya A, Koh K, Ogata M, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Itabashi K, Yamaguchi K, Kuroda M, Watanabe T, Okuma K, and Hamaguchi I.
Proviral features of human T cell leukemia virus type 1 in carriers with indeterminate western blot analysis results.
Journal of Clinical Microbiology, 55(9):2838-2849, 2017.

Kawano N, Kuriyama T, Yoshida S, Kawano S, Yamano Y, Marutsuka K, Minato S, Yamashita K, Ochiai H, Shimoda K, Ishikawa F, Kikuchi I.
The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
J Clin Exp Hematop, 56(3):135-144, 2017.

Coler-Reilly ALG, Sato T, Matsuzaki T, Nakagawa M, Niino M, Nagai M, Nakamura T, Takenouchi N, Araya N, Yagishita N, Inoue E, Yamano Y.
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.
Neurotherapeutics, 14(4):1084-1094, 2017.

Terada Y, Kamoi K, Ohno-Matsui K, Miyata K, Yamano C, Coler-Reilly A, Yamano Y.
Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report.
Medicine (Baltimore), 96(6):e6021, 2017.

Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V, Coelho-Dos-Reis J, Esparza J, Gallo RC, Gessain A, Gotuzzo E, Hall W, Harford J, Hermine O, Jacobson S, Macchi B, Macpherson C, Mahieux R, Matsuoka M, Murphy E, Peloponese JM, Simon V, Tagaya Y, Taylor GP, Watanabe T, Yamano Y.
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
Antiviral Res, 137:41-48, 2017.

Yamano Y, Coler-Reilly A.
HTLV-1 induces a Th1-like state in CD4+ CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM/TSP.
Journal of Neuroimmunology, 304:51-55, 2017.

Yagishita N, Aratani S, Fujita H, Yamano Y, Nishioka K and Nakajima T.
Synoviolin is a Novel Pathogenic Factor of Arthropathy and Chronic Inflammattiion.
New Developments in the Pathogenesis of Rheumatoid Arthritis, 123-135／162, INTECH, February 22, 2017.

Yamano A, Yamano Y, Jacobson S.
Neuroimmunomodulation of Human T-Lymphotrophic Virus Type I/II Infection.
Neuroimmune Pharmacology, 421-436, 2017.

山野嘉久.
HTLV-1関連脊髄症に対するヒト化抗CCR4抗体療法開発の背景
神経治療学, 34(4):453-457, 2017.

山野嘉久.
HTLV-1関連脊髄症.
CareNet希少疾病ライブラリ, 2017.

八木下尚子、 山野嘉久.
HAM患者レジストリ「HAMねっと」によるリアルワールドデータの活用.
月刊PHARMSTAGE, 17(6):19-22, 2017.

八木下尚子、中島利博.
関節リウマチ発症因子　シノビオリン
アレルギーの臨床, 37(9):72-78, 2017.

山野嘉久.
HTLV-1関連脊髄症の診断と治療.
日本内科学会雑誌, 106(7):1404-1409, 2017.

新谷奈津美、山野嘉久.
HTLV-1関連脊髄症(HAM)の分子病態と治療
血液内科, 74(3):373-379, 2017.